Study identifies new biomarkers of Alzheimer's disease

by Ingrid Fadelli , Medical XpressStudy overview. Credit:Nature Human Behaviour(2024). DOI: 10.1038/s41562-024-01924-6Recent advances in the study of proteomes (i.e., the entire range of p

Updated on: July 31,2024

Study identifies new biomarkers of Alzheimer's disease

by Ingrid Fadelli , Medical XpressStudy overview. Credit:Nature Human Behaviour(2024). DOI: 10.1038/s41562-024-01924-6Recent advances in the study of proteomes (i.e., the entire range of p

Updated on:July 31,2024

Gut bacteria changes could signal onset of rare genetic disease

by Georgia Gowing,Macquarie UniversityGraphical abstract. Credit:Neurobiology of Disease(2023). DOI: 10.1016/j.nbd.2023.106051New research may have uncovered a relationship between c

Updated on: February 05,2024

Gut bacteria changes could signal onset of rare genetic disease

by Georgia Gowing,Macquarie UniversityGraphical abstract. Credit:Neurobiology of Disease(2023). DOI: 10.1016/j.nbd.2023.106051New research may have uncovered a relationship between c

Updated on:February 05,2024

Alzheimer's linked to the brain's 'garbage disposal service'

by Andrew Spence, The LeadPET scan of a human brain with Alzheimer's disease. Credit: public domainResearchers in South Australia have found a genetic link between Alzheimer's disease and the

Updated on: April 25,2024

Alzheimer's linked to the brain's 'garbage disposal service'

by Andrew Spence, The LeadPET scan of a human brain with Alzheimer's disease. Credit: public domainResearchers in South Australia have found a genetic link between Alzheimer's disease and the

Updated on:April 25,2024

Chaperone protein imbalance promotes toxic tau buildup in the aging brain

by University of South FloridaTau pathology resembling that seen in Alzheimer's disease brains. Credit: Laura Blair's laboratory, USF Health/University of South FloridaChaperone protein i

Updated on: April 25,2024

Chaperone protein imbalance promotes toxic tau buildup in the aging brain

by University of South FloridaTau pathology resembling that seen in Alzheimer's disease brains. Credit: Laura Blair's laboratory, USF Health/University of South FloridaChaperone protein i

Updated on:April 25,2024

Untangling the threads of early onset dementia

by Lynda De Widt, Mayo Clinic News NetworkCredit: Pixabay/CC0 Public DomainChanges in personality, behavior and language are hallmarks of frontotemporal dementia (FTD), the most common form of dementi

Updated on: April 06,2024

Untangling the threads of early onset dementia

by Lynda De Widt, Mayo Clinic News NetworkCredit: Pixabay/CC0 Public DomainChanges in personality, behavior and language are hallmarks of frontotemporal dementia (FTD), the most common form of dementi

Updated on:April 06,2024

'Didn't understand my suffering': When children get migraines

Credit: Unsplash/CC0 Public DomainMaiwenn Colleaux was 14 when she first started getting migraines, and they immediately turned her life upside down."When I had an attack, I could no longer go ou

Updated on: January 21,2024

'Didn't understand my suffering': When children get migraines

Credit: Unsplash/CC0 Public DomainMaiwenn Colleaux was 14 when she first started getting migraines, and they immediately turned her life upside down."When I had an attack, I could no longer go ou

Updated on:January 21,2024

3D imaging helps to better understand the early stages of Alzheimer's disease

by Karolinska InstitutetNoradrenergic neurons of the human locus coeruleus shell in three dimension. Credit: Gilvesy et al.Using a novel 3D imaging technology, researchers at Karolinska Institute

Updated on: March 13,2024

3D imaging helps to better understand the early stages of Alzheimer's disease

by Karolinska InstitutetNoradrenergic neurons of the human locus coeruleus shell in three dimension. Credit: Gilvesy et al.Using a novel 3D imaging technology, researchers at Karolinska Institute

Updated on:March 13,2024

A multi-faceted approach to improve Alzheimer's diagnosis

by David Bradley,InderscienceCredit: Pixabay/CC0 Public DomainAreviewin theInternational Journal of Medical Engineering and Informaticshas surveyed current early detectio

Updated on: March 02,2024

A multi-faceted approach to improve Alzheimer's diagnosis

by David Bradley,InderscienceCredit: Pixabay/CC0 Public DomainAreviewin theInternational Journal of Medical Engineering and Informaticshas surveyed current early detectio

Updated on:March 02,2024

Brain changes may fuel 'long COVID' anxiety, confusion

Credit: Pixabay/CC0 Public DomainHere's more evidence of the toll that COVID-19 takes on the human brain: A new study finds biomarkers of neuron damage and brain inflammation in the blood are asso

Updated on: February 18,2024

Brain changes may fuel 'long COVID' anxiety, confusion

Credit: Pixabay/CC0 Public DomainHere's more evidence of the toll that COVID-19 takes on the human brain: A new study finds biomarkers of neuron damage and brain inflammation in the blood are asso

Updated on:February 18,2024

Discovery of macrophages' protective role for nerve damage opens new treatment path

Updated on: March 05,2025

Discovery of macrophages' protective role for nerve damage opens new treatment path

Updated on:March 05,2025

Alzheimer's treatment holds promise for primary progressive aphasia patients

by Northwestern UniversityCredit: CC0 Public DomainNorthwestern Medicine scientists have discovered that an existing therapy frequently used to treat Alzheimer's disease might also work on pa

Updated on: April 08,2024

Alzheimer's treatment holds promise for primary progressive aphasia patients

by Northwestern UniversityCredit: CC0 Public DomainNorthwestern Medicine scientists have discovered that an existing therapy frequently used to treat Alzheimer's disease might also work on pa

Updated on:April 08,2024

Biogen pulls controversial Alzheimer's drug Aduhelm

Biogen said it was discontinuing Aduhelm to put more resources into Leqembi, a newer Alzheimer's medicine that was fully approved in 2023 under the traditional regulatory pathway.A controversial A

Updated on: March 24,2024

Biogen pulls controversial Alzheimer's drug Aduhelm

Biogen said it was discontinuing Aduhelm to put more resources into Leqembi, a newer Alzheimer's medicine that was fully approved in 2023 under the traditional regulatory pathway.A controversial A

Updated on:March 24,2024